Project description DEENESFRITPL Artificial intelligence in cancer diagnosis As the number of cancer cases worldwide increases, there is a pressing need for prompt and accurate cancer diagnosis. Existing approaches are time-consuming and depend heavily on the knowledge and experience of trained pathologists. To overcome these limitations, the EU-funded AIPACA project aims to develop an artificial intelligence-based software capable of analysing biopsy slides within seconds to identify tumour regions and quantify tumour biomarkers. The software is expected to significantly reduce biopsy processing time and assist diagnosis through deep learning features. Moreover, it will minimise variations in diagnosis, offering a robust and reliable clinical tool. Show the project objective Hide the project objective Objective MindPeak is an innovative start-up that builds diagnostic support tools for cancer diagnosis. Our Artificial Intelligence (AI) software analyses biopsy slides within seconds to find tumour regions and quantify tumour markers to prepare them for visual inspection by the pathologist. In 2018, the number of diagnosed cancer cases has grown to 18 million globally.Consequently, the demand for cancer diagnosis to determine appropriate treatment has never been higher. Cancer diagnosis nowadays is a very time-consuming process and depends heavily on the knowledge and experience of specialised pathologists. Unfortunately, the number of experts can no longer meet the quickly increasing demand. As a result, patients must wait longer than necessary for their diagnosis.To overcome this challenge, MindPeak provides solutions based on deep learning to support pathologists in their diagnosis. Patients benefit from increased accuracy and a faster turn around time of diagnosis as well as reduced costs. The key USP of our AI is its reliability in the clinical context with its variations across and within labs. Funding from the EIC Accelerator will help us with a successful and fast go-to-market of our solutions that cover crucial improvements for cancer patients. With our technology, we address the market for pathology with a current size of $17.3 bn worldwide and an annual growth rate of 6.5%. Fields of science natural sciencescomputer and information sciencessoftwaremedical and health sciencesclinical medicineoncologymedical and health sciencesbasic medicinepathologynatural sciencescomputer and information sciencesartificial intelligencemachine learningdeep learning Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Topic(s) EIC-SMEInst-2018-2020 - SME instrument Call for proposal H2020-EIC-SMEInst-2018-2020 See other projects for this call Sub call H2020-EIC-SMEInst-2018-2020-3 Funding Scheme SME-2b - SME Instrument (grant only and blended finance) Coordinator MINDPEAK GMBH Net EU contribution € 1 372 378,00 Address Zirkusweg 2 20359 Hamburg Germany See on map Region Hamburg Hamburg Hamburg Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 588 162,00
